or Try an Advanced Search...

    Technical Analysis for MGRX - Mangoceuticals, Inc.

    Grade Last Price % Change Price Change
    D 0.33 7.57% 0.02
    MGRX closed up 7.57 percent on Monday, July 1, 2024, on 2 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical MGRX trend table...
    Date Alert Name Type % Chg
    Crossed Above 50 DMA Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    Narrow Range Bar Range Contraction 7.57%
    Stochastic Reached Oversold Weakness 7.57%
    Wide Bands Range Expansion 7.57%
    Oversold Stochastic Weakness 7.57%
    Fell Below 50 DMA Bearish 1.24%
    Narrow Range Bar Range Contraction 1.24%
    Wide Bands Range Expansion 1.24%
    Crossed Above 50 DMA Bullish -0.91%
    Older End-of-Day Signals for MGRX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 8 hours ago
    50 DMA Resistance about 8 hours ago
    10 DMA Resistance about 8 hours ago
    Up 5% about 8 hours ago
    Up 3% about 8 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    MGRX Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Mangoceuticals, Inc. focuses to develop, market, and sell various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
    Classification
    Sector: Healthcare
    Industry: Health Information Services
    Keywords: Telehealth Telemedicine Wellness Products Erectile Dysfunction

    Is MGRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 6 MangoRx gets notice of acceptance for patent application in Australia
    Jun 6 MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology
    Jun 4 Mangoceuticals stock rallies on Japanese patent allowance
    Jun 4 MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies
    Jun 4 MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances
    May 23 MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts
    May 22 12 Consumer Staples Stocks Moving In Wednesday's Pre-Market Session
    May 21 Microcap Mangoceuticals doubles on plan to sell cheap oral GLP-1 weight loss meds
    May 21 MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications
    May 16 Mangoceuticals reports Q1 results
    See more MGRX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.95
    52 Week Low 0.143
    Average Volume 6,363,142
    200-Day Moving Average 0.42
    50-Day Moving Average 0.32
    20-Day Moving Average 0.35
    10-Day Moving Average 0.32
    Average True Range 0.05
    RSI (14) 48.19
    ADX 41.19
    +DI 30.60
    -DI 14.14
    Chandelier Exit (Long, 3 ATRs) 0.29
    Chandelier Exit (Short, 3 ATRs) 0.44
    Upper Bollinger Bands 0.42
    Lower Bollinger Band 0.28
    Percent B (%b) 0.35
    BandWidth 41.17
    MACD Line -0.01
    MACD Signal Line 0.00
    MACD Histogram -0.0065
    Fundamentals Value
    Market Cap 7.2 Million
    Num Shares 22 Million
    EPS -0.44
    Price-to-Earnings (P/E) Ratio -0.74
    Price-to-Sales 12.35
    Price-to-Book 6.49
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.37
    Resistance 3 (R3) 0.37 0.35 0.37
    Resistance 2 (R2) 0.35 0.34 0.35 0.36
    Resistance 1 (R1) 0.34 0.33 0.35 0.34 0.36
    Pivot Point 0.32 0.32 0.33 0.32 0.32
    Support 1 (S1) 0.31 0.31 0.32 0.31 0.29
    Support 2 (S2) 0.29 0.30 0.29 0.29
    Support 3 (S3) 0.28 0.29 0.29
    Support 4 (S4) 0.28